-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Rhythm Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2020 to Q1 2025.
- Rhythm Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2025 was -0.81 USD/shares, a 65.5% increase year-over-year.
- Rhythm Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2025 was -2.8 USD/shares, a 39.5% increase year-over-year.
- Rhythm Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -4.34 USD/shares, a 35.6% decline from 2023.
- Rhythm Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.2 USD/shares, a 7.78% increase from 2022.
- Rhythm Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -3.47 USD/shares, a 148% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)